Innate immunity and vaccines in chlamydial infection with special emphasis on Chlamydia pneumoniae

FEMS Immunology and Medical Microbiology

Volumn 55, Issue 2, 2009, Pages 167-177

  Puolakkainen, Mirja ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Chlamydia pneumoniae; Innate immunity; Toll like receptor; Vaccine

Indexed keywords

BACTERIAL VACCINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; CHLAMYDIA PNEUMONIAE VACCINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONFERENCE PAPER; DRUG DESIGN; GENOMICS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INFECTION SENSITIVITY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS; VACCINATION; VACCINE PRODUCTION;

BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; IMMUNITY, INNATE;

EID: 60049089381     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00519.x     Document Type: Conference Paper

References (120)

1. Akira S, Uematsu S Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124 : 783 801.
2. Bals R Hiemstra PS (2004) Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 23 : 327 333.
3. Balsara ZR Starnbach MN (2006) CD8+ T cell recognition of cell infected with Chlamydia. Chlamydia, Genomics and Pathogenesis (Bavoil PM Wyrick PB, eds), pp. 381 411. Horizon Bioscience, Norfolk, UK.
4. Bas S, Neff L, Vuillet M, Spenato U, Seya T, Matsumoto M Gabay C (2008) The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J Immunol 180 : 1158 1168.
5. Bea F, Puolakkainen MH, McMillen T, Hudson FN, Mackman N, Kuo CC, Campbell LA Rosenfeld ME (2003) Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circ Res 92 : 394 401.
6. Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL Caldwell HD (2003) Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. P Natl Acad Sci USA 100 : 15971 15976.
7. Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN Dietrich WF (2006) Genetic analyses of susceptibility to Chlamydia trachomatis in mouse. Genes Immun 7 : 122 129.
8. Bissonnette L Bergeron MG (2006) Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine. Expert Rev Mol Diagn 6 : 433 450.
9. Brunham RC, Pourbohloul B, Mak S, White R Rekart ML (2005) The unexpected impact of a Chlamydia trachomatis Infection Control Program on Susceptibility to Reinfection. J Infect Dis 192 : 1836 1844.
10. Brunham RC, Pourbohloul B, Mak S, White R Rekart ML (2006) Correspondence. J Infect Dis 193 : 1338 1339.
11. Buchholz KR Stephens RS (2008) The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun 76 : 3150 3155.
12. Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP Arditi M (2002) Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol 168 : 1435 1440.
13. Cao F, Castrillo A, Tontonoz P, Re F Byrne GI (2007) Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75 : 753 759.
14. Carneiro LAM, Travassos LH Girardin SE (2007) Nod-like receptors in innate immunity and inflammatory diseases. Ann Med 39 : 581 593.
15. Chopra I, Storey CC, Falla TJ Pearce JH (1998) Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited. Microbiology 144 : 2673 2678.
16. Cirl C, Wieser A, Yadav M et al 2008) Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain - containing proteins. Nat Med 14 : 399 406.
17. Cook DN, Pisetsky DS Schwartz DA (2004) Toll-like receptors in the pathogenesis of human disease. Nat Immunol 5 : 975 979.
18. Cooper M, Roberts M, Potter J Jarvis G (2008) Influence of Chlamydia trachomatis serovar D and E on TREM-1 expression in human reproductive tract epithelial cells. Proceedings of the Sixth Meeting of the European Society for Chlamydia Research (Christiansen G, ed), p. 370. Narayana Press, Gylling, Odder, Denmark.
19. Costa CP, Kirschning CJ, Busch D, Dürr S, Jennen L, Heinzmann U, Prebeck S, Wagner H Miethke T (2002) Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. Eur J Immunol 32 : 2460 2470.
20. da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H Miethke T (2004) Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol 34 : 2874 2884.
21. Darville T (2006) Innate immunity. Chlamydia, Genomics and Pathogenesis (Bavoil PM Wyrick PB, eds), pp. 339 363. Horizon Bioscience, Norfolk, UK.
22. Darville T, O'Neill JM, Andrews Jr. CW, Nagarajan UM, Stahl L Ojcius DM (2003) Toll-like receptor-2, but not Toll-like receptor-4, is essential for the development of oviduct pathology in chlamydial genital tract infection. J Immunol 171 : 6187 6197.
23. Davies MN Flower DR (2007) Harnessing bioinformatics to discover new vaccines. Drug Discov Today 12 : 389 395.
24. Dechend R, Mass M, Gieggers J, Dietz R, Scheidereit C, Leutz A Gulba DC (1999) Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation 100 : 1369 1373.
25. De Groot AS (2006) Immunomics: discovering new targets for vaccines and therapeutics. Drug Discov Today 11 : 203 209.
26. den Hartog JE, Ouburg S, Land JA, Lyons JM, Ito JI, Pena AS Morré SA (2006) Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women. BMC Infect Dis 6 : 122.
27. Derbigny WA, Kerr MS Johnson RM (2005) Pattern recognition molecules activated by Chlamydia muridarum infection of cloned murine oviduct epithelial cell lines. J Immunol 175 : 6065 6075.
28. Derbigny WA, Hong SC, Kerr MS, Temkit M Johnson RM (2007) Chlamydia muridarum infection elicits a beta interferon response in murine oviduct epithelial cells dependent on interferon regulatory factor 3 and TRIF. Infect Immun 75 : 1280 1290.
29. Droemann D, Rupp J, Goldmann T, Uhlig U, Branscheid D, Vollmer E, Kujath P, Zabel P Dalhoff K (2007) Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease. Am J Resp Crit Care 175 : 791 797.
30. Eddie B Meyer KF (1956) The influence of tetracycline compounds on the development of antibodies in psittacosis. Am Rev Tuberc 74 : 566 571.
31. Equils O, Lu D, Gatter M, Witkin SS, Bertolotto C, Arditi M, McGregor JA, Simmons CF Hobel CJ (2006) Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. J Immunol 177 : 1257 1263.
32. Erridge C, Pridmore A, Elev A, Stewart J Poxton IR (2004) Lipopolysaccharide of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 53 : 735 740.
33. Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG Núñez G (2008) Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 10 : 1 8.
34. Gencay MM, Tamm M, Glanville A, Perruchoud AP Roth M (2003) Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor. Infect Immun 71 : 5814 5822.
35. Giuliani MM, Adu-Bobie J, Comanducci M et al 2006) A universal vaccine for serogroup B meningococcus. P Natl Acad Sci USA 103 : 10834 10839.
36. Godzik KL, O'Brien ER, Wang SK Kuo CC (1995) In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33 : 2411 2414.
37. Hippenstiel S, Opitz B, Schmeck B Suttorp N (2006) Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Resp Res 7 : 97.
38. Hsia RC, Pannekoek Y, Ingerowski E Bavoil PM (1997) Type III secretion genes identify a putative virulence locus of Chlamydia. Mol Microbiol 25 : 351 359.
39. Huang J, DeGraves FJ, Lenz SD, Gao D, Feng P, Li D, Schlapp T Kaltenboeck B (2002) The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease. P Natl Acad Sci USA 99 : 3914 3919.
40. Ishii KJ, Koyama S, Nakagawa A, Coban C Akira S (2008) Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3 : 352 363.
41. Jiang SJ, Kuo CC, Berry MW, Lee AW Campbell LA (2008) Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages. Infect Immun 76 : 1558 1564.
42. Joyee AG Yang X (2008) Role of toll-like receptors in immune responses to chlamydial infections. Curr Pharm Design 14 : 593 600.
43. Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, Hyman RW, Olinger L, Grimwood J, Davis RW Stephens RS (1999) Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet 21 : 385 389.
44. Kaukoranta-Tolvanen SS, Teppo AM, Laitinen K, Saikku P, Linnavuori K Leinonen M (1996) Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathogenesis 21 : 215 221.
45. Kawai T Akira S (2005) Pathogen recognition with Toll-like receptors. Curr Opin Immunol 17 : 338 344.
46. Kawai T Akira S (2007) TLR signaling. Semin Immunol 19 : 24 32.
47. Klesney-Tait J, Turnbull IR Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7 : 1266 1273.
48. Kol A, Bourcier T, Lichtman AH Libby P (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103 : 571 577.
49. Kuo CC, Puolakkainen M, Lin TM, Witte M Campbell LA (2002) Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb Pathogenesis 32 : 43 48.
50. Lyytikäinen E, Kaasila M, Koskela P, Lehtinen M, Patama T, Pukkala E, Tasanen K, Surcell HM Paavonen J (2008) Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect 84 : 19 22.
51. McDonald C, Inohara N Núñez G (2005) Peptidoglycan signaling in innate immunity and inflammatory disease. J Biol Chem 280 : 20177 20180.
52. Madsen HO, Videm V, Svejgaard A, Svennevig JL Garred P (1998) Association of mannose-binding lectin deficiency with severe atherosclerosis. Lancet 352 : 959 960.
53. Maguire M, Poole S, Coates AR, Tormay P, Wheeler-Jones C Henderson B (2005) Comparative cell signalling activity of ultrapure recombinant chaperonin 60 proteins from prokaryotes and eukaryotes. Immunology 115 : 231 238.
54. Mannonen L, Kamping E, Penttilä T Puolakkainen M (2004) IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. Microb Pathogenesis 36 : 41 50.
55. Mayer AK Dalpke AH (2007) Regulation of local immunity by airway epithelial cells. Arch Immunol Ther 55 : 353 362.
56. McClarty G, Caldwell HD Nelson DE (2007) Chlamydial interferon gamma immune evasion influences infection tropism. Curr Opin Microbiol 10 : 47 51.
57. Min-Oo G, Lindqvist L, Wang C, Fortin P, Li Y, Kaltenboeck B Gros P (2007) Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniae in the mouse. Genes Immun 4 : 383 388.
58. Misch AE Hawn TR (2008) Toll-like receptor polymorphisms and susceptibility to human disease. Clin Sci 114 : 347 360.
59. Miyairi I, Arva Tatireddigari VRR, Mahdi OS, Rose LA, Bellend RJ, Lu L, Williams RW Byrne GI (2007) The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol 179 : 1814 1824.
60. Moazed TC, Kuo CC, Grayston JT Campbell LA (1998) Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177 : 1322 1325.
61. Molestina RE, Klein JB, Miller RD, Pierce WH, Ramirez JA Summersgill JT (2002) Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun 70 : 2976 2981.
62. Montigiani S, Falugi F, Scarselli M et al 2002) Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun 70 : 368 379.
63. Mozzato-Chamay N, Mahdi OS, Jallow O, Mabey DC, Bailey RL Conway DJ (2000) Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis - endemic population. J Infect Dis 182 : 1545 1548.
64. Mukhopadhyay S, Miller RD, Sullivan ED, Theodoropoulos C, Mathews SA, Timms P Summersgill JT (2006) Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response. Infect Immun 74 : 3853 3863.
65. Munford RS (2008) Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect Immun 76 : 454 465.
66. Murdin AD, Dunn P, Sodoyer R, Wang J, Caterini J, Brunham RC, Aujame L Oomen R (2000) Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection. J Infect Dis 181 (suppl 3) : S544 S551.
67. Murthy AK, Chambers JP, Meier PA, Zhong G Arulanandam BP (2007) Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect Immun 75 : 666 676.
68. Nagarajan UM, Ojcius DM, Stahl L, Rank RG Darville T (2005) Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. J Immunol 175 : 450 460.
69. Naiki Y, Michelsen KS, Schröder NW et al 2005) MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem 280 : 29242 29249.
70. Natividad A, Wilson J, Koch O et al 2005) Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 6 : 332 340.
71. Nelson DE, Virok DP, Wood H et al 2005) Chlamydial IFN-gamma immune evasion is linked to host infection tropism. P Natl Acad Sci USA 102 : 10658 10663.
72. Netea MG, Kullberg BJ, Galama JM, Stalenhof AF, Dinarello CA Van der Meer JW (2002) Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways. Eur J Immunol 32 : 1188 1195.
73. Netea MG, Kullberg BJ, Jacobs LE, Verver-Jansen TJ, van der Ven-Jongekrig J, Galama JM, Stalenhof AF, Dinarello CA Van der Meer JW (2004) Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release. J Immunol 173 : 1477 1482.
74. O'Connell CM, Ionova IA, Quayle AJ, Visintin A Ingalls RR (2006) Localization of TLR2 and MyD88 to Chlamydia trachomatis inclusions. Evidence for signaling by intracellular TLR2 during infection with an obligate intracellular pathogen. J Biol Chem 281 : 1652 1659.
75. Öhman H, Tiitinen A, Halttunen M, Birkelund S, Christiansen G, Koskela P, Lehtinen M, Paavonen J Surcel HM (2006) IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis. Genes Immun 7 : 243 249.
76. Opitz B, Förster S, Hocke AC, Maass M, Schmeck B, Hippenstiel S, Suttorp N Krull M (2005) Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res 96 : 319 326.
77. Ouellette SP, Hatch TP, AbdelRahman YM, Rose LA, Belland RJ Byrne GI (2006) Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFN gamma-mediated host cell tryptophan starvation. Mol Microbiol 62 : 1387 1401.
78. Paju S, Goulhen F, Asikainen S, Grenier D, Mayrand D Uitto V (2000) Localization of heat shock proteins in clinical Actinobacillus actinomycetemcomitans strains and their effects on epithelial cell proliferation. FEMS Microbiol Lett 182 : 231 235.
79. Pålsson-McDermott EM O'Neill LAJ (2007) Building an immune system from nine domains. Biochem Soc T 35 : 1437 1444.
80. Pedersen AS, Christiansen G Birkelund S (2001) Differential expression of Pmp10 in cell culture infected with Chlamydia pneumoniae CWL029. FEMS Microbiol Lett 203 : 153 159.
81. Penttilä JM, Anttila M, Varkila K, Puolakkainen M, Sarvas M, Mäkelä PH Rautonen N (1999) Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice. Immunology 97 : 490 496.
82. Penttilä T, Vuola JM, Puurula V, Anttila M, Sarvas M, Rautonen N, Mäkelä PH Puolakkainen M (2000) Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2). Vaccine 19 : 1256 1265.
83. Penttilä T, Wahlström E, Vuola JM, Sarvas M Puolakkainen M (2006) Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice. Comp Med 56 : 272 278.
84. Pinchuk I, Starcher BC, Livingston B, Tvninnereim A, Wu S, Appella E, Sidney J, Sette A Wizel B (2005) A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae. J Immunol 174 : 5729 5739.
85. Poland GA, Ovsyannikova IG, Jacobson RM Smith DI (2007) Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin Pharmacol Ther 82 : 653 664.
86. Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167 : 3316 3323.
87. Puolakkainen M, Parker J, Kuo CC, Grayston JT Campbell LA (1995) Further characterization of Chlamydia pneumoniae specific monoclonal antibodies. Microbiol Immunol 39 : 551 554.
88. Rank RG (2006) The role of the CD4 T cell in the host response to Chlamydia. Chlamydia, Genomics and Pathogenesis (Bavoil PM Wyrick PB, eds), pp. 365 379. Horizon Bioscience, Norfolk, UK.
89. Rantala A, Lajunen T, Juvonen R, Paldanius M, Saikku P Leinonen M (2008) The association of MBL levels and MBL2 gene polymorphisms with Chlamydia pneumoniae seroconversions during military service. Proceedings of the Sixth Meeting of the European Society for Chlamydia Research (Christiansen G, ed), p. 284. Narayana Press, Gylling, Odder, Denmark.
90. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS Kagnoff MF (1997) Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 99 : 77 87.
91. Roan NR Starnbach MN (2008) Immune-mediated control of Chlamydia infection. Cell Microbiol 10 : 9 19.
92. Robinson MJ, Sancho D, Slack EC, LeibundGut-Landmann S Reis e Sousa C (2006) Myeloid C-type lectins in innate immunity. Nat Immunol 7 : 1258 1265.
93. Rodríguez A, Rottenberg M, Tjärnlund A Fernández C (2006) Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae. Scand J Immunol 63 : 177 183.
94. Rodríguez N, Mages J, Dietrich H, Wantia N, Wagner H, Lang R Miethke T (2007) MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol Genomics 30 : 134 145.
95. Roshick C, Wood H, Caldwell HD McClarty G (2006) Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun 74 : 225 238.
96. Rothfuchs AG, Trumstedt C, Wigzell H Rottenberg ME (2004) Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. J Immunol 172 : 6345 6353.
97. Rottenberg ME, Gigliotti Rothfuchs AC, Gigliotti D, Svanholm C, Bandholtz L Wigzell H (1999) Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice. J Immunol 162 : 2829 2836.
98. Rottenberg ME, Gigliotti Rothfuchs A, Gigliotti D, Ceausu M, Une C, Levitsky V Wigzell H (2000) Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae. J Immunol 164 : 4812 4818.
99. Rugonfalvi-Kiss S, Endrész V, Madsen HO et al 2002) Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 106 : 1071 1076.
100. Rupp J, Goebel W, Kramme E, Jahn J, Solbach W Mass M (2004) CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes. Genes Immun 5 : 435 438.
101. Sambri V, Donati M, Storni E, Di Leo K, Agnusdei M, Petracca R, Finco O, Grandi G, Ratti G Cevenini R (2004) Experimental infection by Chlamydia pneumoniae in the hamster. Vaccine 22 : 1131 1137.
102. Sansonetti PJ (2006) The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7 : 1237 1242.
103. Sarén A, Pascolo S, Stevanovic S, Dumrese T, Puolakkainen M, Sarvas M, Rammensee HG Vuola JM (2002) Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun 70 : 3336 3343.
104. Stephens RS, Kalman S, Lammel C et al 1998) Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 23 : 754 759.
105. Subtil A, Delevoye C, Balañá ME, Tastevin L, Perrinet S Dautry-Varsat A (2005) A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Mol Microbiol 56 : 1636 1647.
106. Svanholm C, Bandholtz L, Castaños-Velez E, Wigzell H Rottenberg ME (2000) Protective DNA immunization against Chlamydia pneumoniae. Scand J Immunol 51 : 345 353.
107. Swanson AF, Ezekowitz RA, Lee A Kuo CC (1998) Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun 66 : 1607 1612.
108. Sziller I, Babula O, Ujházy A, Nagy B, Hupuczi P, Papp Z, Linhares IM, Ledger WJ Witkin SS (2007) Chlamydia trachomatis infection, Fallopian tube damage and a mannose-binding lectin codon 54 gene polymorphism. Hum Reprod 22 : 1861 1865.
109. Takeda K Akira S (2005) Toll-like receptors in innate immunity. Int Immunol 17 : 1 14.
110. Tammiruusu A, Penttilä T, Lahesmaa R, Sarvas M, Puolakkainen M Vuola JM (2007) Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model. Vaccine 25 : 283 290.
111. Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG Girardin SE (2007) The nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol 29 : 289 301.
112. Trumstedt C, Eriksson E, Lundberg AM, Yang TB, Yan ZQ, Wigzell H Rottenberg ME (2007) Role of IRK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae. J Leukocyte Biol 81 : 1591 1598.
113. Tvinnereim A Wizel B (2007) CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent. J Immunol 179 : 3947 3957.
114. Vuola JM, Puurula V, Anttila M, Mäkelä PH Rautonen N (2000) Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge. Infect Immun 68 : 960 964.
115. Welter-Stahl L, Ojcius D, Viala J, Girardin S, Liu W, Delarbe C, Philpott D, Kelly KA Darville T (2006) Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell Microbiol 8 : 1047 1057.
116. Wizemann TM, Heinrichs JH, Adamou JE et al 2001) Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun 69 : 1593 1598.
117. Yang X, Coriolan D Schultz K, Golenbock DT Beasley D (2005) Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. Arterioscl Throm Vas 25 : 2308 2314.
118. Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC Rosenfeld ME (2005a) Effect of Chlamydia pneumoniae on cellular ATP content in mouse macrophages: role of toll-like receptor 2. Infect Immun 73 : 4323 4326.
119. Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC Rosenfeld ME (2005b) Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway. Infect Immun 73 : 4315 4322.
120. Zhong G, Fan P, Ji H, Dong F Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193 : 935 942.